Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Milone

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Molecular Therapy Oncolytics|February 22, 2021
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4Vijay G Bhoj, Lucy Li, Kalpana Parvathaneni, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Cancer Immunology Research|January 21, 2015
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cellsMatthew J Frigault, Jihyun Lee, Maria Ciocca Basil, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Oncotarget|June 15, 2018
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myelomaDe-Xiu Bu, Reshma Singh, Eugene E Choi, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Cell Reports. Medicine|December 20, 2023
Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodiesZheng Zhang, Caroline Markmann, Ming Yu, et al.
The Journal of Clinical Investigation|March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaAdam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Molecular Therapy Oncolytics|February 22, 2021
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4Vijay G Bhoj, Lucy Li, Kalpana Parvathaneni, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Cancer Immunology Research|January 21, 2015
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cellsMatthew J Frigault, Jihyun Lee, Maria Ciocca Basil, et al.
Blood Immunology & Cellular Therapy|April 17, 2026
Viral vector-free generation of orthogonal IL-2-responsive CAR T cells through gene editing of IL-2 and its receptorQian Zhang, Yihao Wu, Jingyi Yang, et al.
Oncotarget|June 15, 2018
Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myelomaDe-Xiu Bu, Reshma Singh, Eugene E Choi, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Cell Reports. Medicine|December 20, 2023
Immunotherapy targeting B cells and long-lived plasma cells effectively eliminates pre-existing donor-specific allo-antibodiesZheng Zhang, Caroline Markmann, Ming Yu, et al.
The Journal of Clinical Investigation|March 22, 2019
B cell maturation antigen-specific CAR T cells are clinically active in multiple myelomaAdam D Cohen, Alfred L Garfall, Edward A Stadtmauer, et al.
The Journal of Clinical Investigation|April 28, 2015
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesisYan Xiang, Zachary E Stine, Jinsong Xia, et al.
Nature Cancer|May 31, 2022
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumorsHongru Zhang, Pengfei Yu, Vivek S Tomar, et al.
Pageof 11